Acadian Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-358,021
| Closed | -$6.09M | – | 2445 |
|
|
2020
Q4 | $6.09M | Sell |
358,021
-282,539
| -44% | -$4.81M | 0.02% | 452 |
|
|
2020
Q3 | $3.01M | Buy |
640,560
+108,952
| +20% | +$512K | 0.01% | 555 |
|
|
2020
Q2 | $3.24M | Buy |
531,608
+105,746
| +25% | +$645K | 0.01% | 591 |
|
|
2020
Q1 | $967K | Buy |
425,862
+175,399
| +70% | +$398K | 0.01% | 801 |
|
|
2019
Q4 | $1.15M | Buy |
250,463
+94,242
| +60% | +$433K | 0.01% | 843 |
|
|
2019
Q3 | $606K | Buy |
156,221
+12,713
| +9% | +$49.3K | ﹤0.01% | 1031 |
|
|
2019
Q2 | $866K | Buy |
143,508
+57,078
| +66% | +$344K | ﹤0.01% | 841 |
|
|
2019
Q1 | $1.16M | Buy |
+86,430
| New | +$1.16M | 0.01% | 840 |
|
|
2017
Q2 | – | Sell |
-249,909
| Closed | -$9.04M | – | 1673 |
|
|
2017
Q1 | $9.04M | Sell |
249,909
-792,480
| -76% | -$28.7M | 0.04% | 306 |
|
|
2016
Q4 | $52.2M | Sell |
1,042,389
-68,943
| -6% | -$3.45M | 0.25% | 97 |
|
|
2016
Q3 | $58.3M | Buy |
1,111,332
+16,964
| +2% | +$890K | 0.29% | 99 |
|
|
2016
Q2 | $45.3M | Buy |
1,094,368
+578,411
| +112% | +$23.9M | 0.23% | 120 |
|
|
2016
Q1 | $21M | Buy |
+515,957
| New | +$21M | 0.11% | 194 |
|
|
2015
Q2 | – | Sell |
-832
| Closed | -$19K | – | 1556 |
|
|
2015
Q1 | $19K | Buy |
+832
| New | +$19K | ﹤0.01% | 1126 |
|